Myasthenia Gravis is an autoimmune disorder that targets the ACh receptors at the NMJ and ultimately reduces the number of available receptors.Predict what happens if you treat the patient with a drug that inhibits the activity of acetylcholinesterase?

Question

Quizplus · Accepted Answer

Inhibiting acetylcholinesterase will increase the duration of acetylcholine activity at the NMJ, thus increasing the likelihood of interaction with remaining ACh receptors. This will increase the strength of the contraction and potentially improve muscle weakness associated with myasthenia gravis.

Myasthenia Gravis Is an Autoimmune Disorder That Targets the ACh